Weekly nab-paclitaxel in combination with carboplatin vs. solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial - Socinski, M A; Bondarenko, I; Karaseva, N A (J Clin Oncol, 2012)
et al.